{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-191566","form_type":"8-K","ticker":"MPLT","cik":"0001770069","company_name":"MapLight Therapeutics, Inc.","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.879306+00:00","generated_at":"2026-05-15T02:21:26.042765+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Two MapLight directors not standing for reelection; Babler and Cox nominated","bullets":["Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D. will not stand for reelection at the June 23, 2026 Annual Meeting.","Board nominated Martin Babler and Troy Cox as Class I director nominees to replace them.","Both departures are not due to any disagreement with the Company on operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-191566","json":"https://secwatch.observer/filing/0001193125-26-191566.json","markdown":"https://secwatch.observer/filing/0001193125-26-191566.md","text":"https://secwatch.observer/filing/0001193125-26-191566.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526191566/0001193125-26-191566-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526191566/d114505d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:21:26.042765+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e89530e5d","claim":"Martin Babler was appointed as Class I Director at MapLight Therapeutics, Inc..","evidence_excerpt":"The Board has nominated Martin Babler and Troy Cox as Class I director nominees to replace Dr. Malenka and Dr. Trenkle.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526191566/0001193125-26-191566-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"nominated"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"},{"claim_id":"4b69b3faee","claim":"Jim Trenkle departed as Director at MapLight Therapeutics, Inc..","evidence_excerpt":"On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the \"Board\") of MapLight Therapeutics, Inc. (the \"Company\") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526191566/0001193125-26-191566-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"91a5038227","claim":"Troy Cox was appointed as Class I Director at MapLight Therapeutics, Inc..","evidence_excerpt":"The Board has nominated Martin Babler and Troy Cox as Class I director nominees to replace Dr. Malenka and Dr. Trenkle.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526191566/0001193125-26-191566-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"nominated"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"},{"claim_id":"ded7921102","claim":"Robert Malenka departed as Director at MapLight Therapeutics, Inc..","evidence_excerpt":"On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the \"Board\") of MapLight Therapeutics, Inc. (the \"Company\") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1770069/000119312526191566/0001193125-26-191566-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for reelection"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}